Ipsen
Specialty biopharma with oncology and rare disease portfolio and a consumer aesthetics product line.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Moderate to Severe Glabellar Lines
A Study to Assess the Effectiveness and Safety of IPN10200 in Adult Chinese Participants With Moderate to Severe Wrinkle-like Lines Between the EyebrowsPhase 3 · Recruiting · Moderate to Severe Glabellar Lines
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary CholangitisPhase 3 · Recruiting · Primary Biliary Cholangitis (PBC)
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing CholangitisPhase 3 · Recruiting · Primary Sclerosing Cholangitis
A Study of IPN10200 for the Treatment of Cervical Dystonia in AdultsPhase 2 · Recruiting · Cervical Dystonia
A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid TumoursPhase 1 · Recruiting · Advanced Solid Tumor
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/ipsen/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.